Germany· DE-A57-131e135244478ba2
Ampicillin Und Sulbactam Ibi
A medicinal product containing ampicillin sodium, sulbactam sodium, registered in Germany by Ibi G. Lorenzini Spa.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ampicillin Sodium, Sulbactam Sodium
- Manufacturer
- Ibi G. Lorenzini Spa
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ampicillin sodium, sulbactam sodium in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesampicillin and sulbactamSagent Pharmaceuticals
- CzechiaAMPICILLIN/SULBACTAM APTAPHARMAApta Medica Internacional d.o.o., Ljubljana
- PolandAmpicilin+Sulbactam AptaPharmaApta Medica Internacional d.o.o.
- SwedenAmpicillin/Sulbactam AptaPharma 1 g/0,5 g Pulver till injektions-/infusionsvätska, lösningAPTA MEDICA INTERNACIONAL
- NetherlandsAmpicilline/Sulbactam AptaPharma 1 g/0,5 g, poeder voor oplossing voor injectie/infusieApta Medica Internacional d.o.o.
- FinlandAmpicillin/Sulbactam AptaPharmaApta Medica Internacional d.o.o.
- NorwayAmpicillin plus Sulbactam eberthEberth
- FranceUNACIM INJECTABLE 0,5 g/1 g, poudre pour usage parentéralPFIZER HOLDING FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Ampicillin/Sulbactam Aptapharma, Unasyn
- Bulgaria · Ампиплюс, Ампицилин/Сулбактам Аптафарма
- Cyprus · Ampicillin/Sulbactam Aptapharma, Begalin-P
- Czechia · Ampicillin And Sulbactam Ibi, Ampicillin/Sulbactam Aptapharma
- Denmark · Ampicillin/Sulbactam Aptapharma
- Estonia · Ampicillin/Sulbactam Auxilia, Ampicillin/Sulbactam Bausch Health
- Finland · Ampicillin/Sulbactam Aptapharma
- France · Unacim Injectable
- Greece · Begalin-P, Demotine
- Croatia · Ampicilin/Sulbaktam Aptapharma
- Hungary · Ampicillin/Sulbactam Aptapharma, Unasyn
- Italy · Ampicillina E Sulbactam Ibi, Unasyn
- Lithuania · Ampicillin/Sulbactam Auxilia
- Malta · Ampicillin/Sulbactam Aptapharma
- Netherlands · Ampicilline/Sulbactam Aptapharma
- Norway · Ampicillin/Sulbactam Aptapharma
- Poland · Ampicilin+sulbactam Aptapharma, Ampicillin Sulbactam Tzf
- Portugal · Ampicilina/Sulbactam Reiwa Healthcare
- Romania · Ampicilină/Sulbactam Aptapharma, Ampiplus
- Sweden · Ampicillin/Sulbactam Aptapharma
- Slovenia · Ampicilin/Sulbaktam Aptapharma
- Slovakia · Ampicilín/Sulbaktám Aptapharma, Ampicillin/Sulbactam Bausch Health
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8da38342-0e81-49e6-8ec6-d7e7da4d4358 GET /v1/drugs/8da38342-0e81-49e6-8ec6-d7e7da4d4358?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use ,Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ampicillin Sodium, Sulbactam Sodium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ampicillin sodium, sulbactam sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.